Keurig Dr Pepper Inc.
KDP · Nasdaq
Analyst Consensus
Analyst Ratings Synthesis
Consensus is Buy, with all 17 tracked analysts supporting that rating. The reported mean price target is $37, but low and high targets are not available, so target clustering and the width of the target spread cannot be assessed. The evidence does not identify the most bullish or least bullish analyst, nor does it provide named firms or individual targets. No rating or price-target revisions are reported for the past week. The substantive debate visible in the research is between expected support from pricing, brand strength, portfolio expansion, volume and premiumization, and the countervailing risks from inflation, tariffs, value-conscious consumers and stubborn costs. Analyst-specific disagreement behind the target mean is not disclosed.
